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Abstract
Differences in mRNA expression levels have been observed in failing versus non-failing human hearts for several membrane
channel proteins and accessory subunits. These differences may play a causal role in electrophysiological changes observed
in human heart failure and atrial fibrillation, such as action potential (AP) prolongation, increased AP triangulation,
decreased intracellular calcium transient (CaT) magnitude and decreased CaT triangulation. Our goal is to investigate
whether the information contained in mRNA measurements can be used to predict cardiac electrophysiological remodeling
in heart failure using computational modeling. Using mRNA data recently obtained from failing and non-failing human
hearts, we construct failing and non-failing cell populations incorporating natural variability and up/down regulation of
channel conductivities. Six biomarkers are calculated for each cell in each population, at cycle lengths between 1500 ms and
300 ms. Regression analysis is performed to determine which ion channels drive biomarker variability in failing versus non-
failing cardiomyocytes. Our models suggest that reported mRNA expression changes are consistent with AP prolongation,
increased AP triangulation, increased CaT duration, decreased CaT triangulation and amplitude, and increased delay
between AP and CaT upstrokes in the failing population. Regression analysis reveals that changes in AP biomarkers are
driven primarily by reduction in IKr, and changes in CaT biomarkers are driven predominantly by reduction in ICaL and
SERCA. In particular, the role of ICaL is pacing rate dependent. Additionally, alternans developed at fast pacing rates for both
failing and non-failing cardiomyocytes, but the underlying mechanisms are different in control and heart failure.
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Introduction
A growing number of studies examine cardiac tissue mRNA
expression levels in an attempt to characterize electrophysiological
remodeling associated with disease conditions such as heart failure
and atrial fibrillation [1–3]. Recent studies have shown alterations
in expression of mRNA transcripts in human failing hearts
compared to non-failing hearts [2,3]. Furthermore, recent optical
mapping measurements have also demonstrated differences in
action potential (AP) and calcium transients (CaT) between failing
and non-failing human hearts [4–6], with potentially pro-
arrhythmic implications [7–10].
Linking mRNA changes to AP and CaT alterations has several
complications, as recently reviewed by Nattel et al [11]. Firstly,
mRNA expression is only one determinant factor of ion channel
expression at the cell membrane. Translation rate, binding with
channel subunits, methylation, membrane localization, trafficking
and phosphorylation all affect the activity of ion channels.
Secondly, expression of mRNA in cardiac cells has been reported
to vary with circadian rhythm [12,13]. And finally, mRNA
expression levels might exhibit variability between tissue samples
due to, for example, gender differences [1,3,14] and spatial
location within the heart [2].
Despite these challenges, mRNA expression data provides
information on heterogeneity and variability in the heart, in both
healthy and diseased states. In this study, we aim to show how
computational modelling can be used to understand the electro-
physiological consequences of differences in mRNA expression
levels between failing and non-failing human hearts. The
methodology proposed is flexible and can be applied to any set
of mRNA measurements and models. We illustrate its potential by
focussing on the ventricular component of the dataset recently
obtained by Ambrosi et al [3]. We will seek to establish whether
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information contained in mRNA transcription data can predict
the functional differences in AP and CaT reported between failing
and non-failing human hearts. We develop an approach that takes
into account potential sources of variability and uncertainty in
both change in conductance due to mRNA expression and
electrophysiological measurements. We construct two cell model
populations based on a human ventricular model [15]. Each
population consists of an ensemble of cell models sharing the same
equations representing ionic current kinetics but different
conductance values. As in [16–20], we incorporate variability,
which may arise from a variety of sources, by using a range of
values for ion channel conductances rather than a single
parameter value. The failing population is then constructed by
additionally incorporating the upregulation or downregulation of
conductances corresponding to mRNA expression changes
reported in heart failure [3].
AP and CaT properties are quantified across both populations
and compared to experimental measurements obtained in failing
and non-failing human ventricles. We then predict the electro-
physiological response of human ventricular myocytes at different
stimulation rates and quantify the relative importance of each
ionic current in determining AP and CaT differences in the
human non-failing and failing cell populations.
Methods
mRNA Expression Data
mRNA expression data [3] are used to determine directions of
changes in ionic conductances in failing versus non-failing human
cardiomyocytes, as summarized in Table 1. Ambrosi et al [3] used
a one-way analysis of variance followed by Tukey-Kramers test
with a significance level of p ƒ 5.6|10{4 based on the
Bonferroni correction 0.05. Three gene transcripts show a trend
towards downregulation in heart failure, contributing to the
conductances of L-type Ca current ICaL (GCaL), transient outward
current Ito (Gto), and the SERCA pump (Jup). Gene transcripts for
the rapid component of the delayed rectifier K current IKr
(HERG) also show a trend towards downregulation and are
included in the simulations by altering the conductance of IKr
(GKr). One gene transcript shows a trend towards upregulation in
the heart failure cases, contributing to the conductance of the Na/
Ca exchange current INaCa (GNaCa). Two further currents are
included in the analysis as they are active during the repolarisation
phase of the action potential, the inward rectifier current IK1 and
the slow component of the delayed rectifier K current IKs. As gene
transcripts associated with these channels show no trend in the
data published in [3] they are considered to have natural
variability only in both populations.
Populations of Human Failing and Non-failing Cell
Models
The O’Hara-Rudy (ORd) human ventricular endocardial
model [15] is used to generate populations of non-failing and
failing cell models. Each population contained 16384 models
sharing the same equations as the ORd model but different
parameter sets. The non-failing population is constructed by
Monte-Carlo sampling of the parameters under investigation (GKr,
GKs, GK1, GCaL, Jup, GNaCa, Gto) from a uniform distribution
between +30% of the original parameter values, in line with
previous studies [16]. This percent variation results in significant
changes in biomarker properties across the population. The
uniform distribution is used as we do not have prior information
on the distribution of conductances in human cardiac myocytes. In
the failing cell population, upregulation is sampled from a uniform
distribution ranging from 0 to +60% change from the original
parameter values and downregulation is sampled in the range -
60% to 0% change from the original parameter values, in line with
mean changes in mRNA expression data [3]. In the failing
population, GK1 and GKs are sampled from the same distribution
as in the non-failing population.
Stimulation Protocol
The stimulation protocol mimics the one used by Lou et al [5] to
obtain optical mapping measurements in failing versus non-failing
cardiomyocytes. Cell models are stimulated for 100 paces at each
of the following basic cycle lengths (BCLs) in a step protocol;
1500 ms, 1000 ms, 900 ms, 800 ms, 700 ms, 600 ms, 500 ms,
450 ms, 400 ms, 350 ms and 300 ms. A stimulus current of
magnitude 280 mA/cm2 and duration 0.5 ms is applied at each
pace.
Biomarkers
As illustrated in Fig. 1, the following biomarkers are calculated
from the two last action potentials simulated for each BCL: AP
duration to 80% repolarisation (APD80), action potential trian-
gulation (APD3080) defined as the ratio between AP duration to
30% repolarisation (APD30) and APD80, CaT duration to 80% of
repolarisation (CaTD80), CaT triangulation (CaTD3080) defined
as the ratio between CaT duration to 30% repolarisation
(CaTD30) and CaTD80, maximum cytosolic calcium concentra-
tion (CaTMax) and the delay between the AP and CaT upstrokes
(DAPCaT). The occurrence of voltage and calcium alternans is
defined as a difference of§5 ms between the APD80 or CaTD80,
respectively, in the penultimate and final APs.
Regression Analysis
To quantify the relative importance of ionic conductances in
determining changes in the biomarkers, linear regression [21,22] is
performed on the failing and non-failing populations, leaving out
the cases showing alternans in APD80 or CaTD80. For each
population, the following procedure is applied for each biomarker.
Biomarker outputs are mean centred and normalised with respect
to their standard deviation at each BCL, as in previous studies
[21]. We seek linear regression coefficients bi for each of the
i~1, . . . ,n parameters under investigation such that for each of
our j~1, . . . ,m cells we have that the cell’s predicted biomarker
output y
p
j is given by
Table 1. Parameters under investigation.
Gene Current Parameter Regulation in HF [3]
KChIP2 Ito, ICaL (a) Gto, GCaL Q
NCX1 INaCa GNaCa q (b)
Serca2A SERCA Jup Q
Kv4.3 Ito Gto Q (c)
Kv11.1/HERG IKr GKr Q (c)
Kv7.1 IKs GKs –
Kir2.1 IK1 GK1 –
a) KChIP2 has recently been shown to form an accessory subunit of ICaL [40].
b) NCX1 was downregulated in non-ischæmic cardiac myopathy patients but
showed no difference from the non-failing group in ischæmic cardiac
myopathy.
c) Kv4.3 and HERG tended to be downregulated relative to the non-failing group
however the difference was not statistically significant.
doi:10.1371/journal.pone.0056359.t001
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y
p
j~
Xn
i~1
bixij , j~1, . . . ,m
where j denotes the current cell, and xij denotes the scaling of the
ith conductance for the jth cell. This may be re-written as the
matrix system
Yp~Xb,
where the coefficients of Yp are (y
p
j ), the coefficients of X are (xij)
and the coefficients of b are (bi). Let Y have coefficients (yj), the
computed biomarker values for each cell. We wish to find a
solution b such that the least squares difference between yj and y
p
j
is minimised over all cells j. This solution is given by
b~(XTX){1XTY: The vector b then contains our linear
regression coefficients. This is repeated for each biomarker at
each BCL.
To determine the effectiveness of this fit, the correlation
coefficient R2 (R-squared) is computed for each linear regression
fit. This coefficient is computed as
R2~1{
Pm
j~1
(y
p
j{yj)
2
(m{1)Var (Y)
:
The closer R2 is to one, the more of the variance in the data is
accounted for by the linear fit.
Numerical Methods
All numerical simulations are performed using our open source
cardiac simulation software Chaste [23]. A CellML [24] imple-
mentation of the ORd model is used from the functional curation
database available within Chaste [25]. The ordinary differential
equations are integrated using the numerical ODE software
package CVODE (https://computation.llnl.gov/casc/sundials/)
called from Chaste. A backward differentiation formula method is
used to integrate the differential equations with absolute and
relative error tolerances 10{5 and 10{7 respectively. The output
time step for biomarker calculation was 1 ms. All postprocessing of
traces to calculate biomarker values was performed within the
Chaste environment. Analysis of biomarkers was performed using
Matlab. A Chaste user project containing the simulation codes
used in this study is available to download from the Chaste website
(http://www.cs.ox.ac.uk/chaste). Matlab data analysis scripts are
also included. All simulations are performed on a 512 core cluster
utilising 2.8GHz Intel processors at the Oxford Supercomputing
Centre (OSC).
Results
Voltage and Calcium Transients in Non-failing and Failing
Populations
Fig. 2 shows sample AP and Ca transients from the non-failing
and failing populations at BCLs of 1500 ms and 300 ms.
Histograms based on these traces, shown in Fig. 3, illustrate the
variability encountered across populations for each biomarker.
Simulation results show significant differences in biomarker values
between the failing and non-failing populations at all BCLs, but an
overlap between the two populations also exists. The circle in each
panel indicates the biomarker value obtained using the standard
ORd model. The cross in each panel indicates the biomarker
value obtained by including specific values of 60% downregulation
of GCaL, Gto, GKr and Jup and 60% upregulation of GNaCa as
indicated by the mean change in mRNA expression in Ambrosi
et al [3] (therefore without considering electrophysological vari-
ability and uncertainty in ionic currents and electrophysiological
measurements). As expected, biomarker values in the non-failing
population are centered around results marked by the circle. In
contrast, the cross is often located at the higher end of biomarker
values for APD80, CaTD80, CaTD3080 and DAPCaT and at the
lower end for APD3080, which could lead to an overestimation of
remodeling-related changes. Results corresponding to each
biomarker are discussed in detail below, and compared to
previously published experimental studies, summarized in
Table 2. A summary of the experimental data may be found in
Tables S1–S7 in Supplement S1.
AP duration. As shown in Fig. 3 A–C, APD80 values in the
non-failing population range between 201 and 362 ms for
BCL = 1500 ms and between 158 and 248 ms for BCL = 300 ms.
Introducing mRNA expression changes associated with heart
failure results in prolonged APD80 values in the failing population
with a 19.6% median increase at all BCLs. APD80 values in the
Figure 1. Biomarkers calculated from AP and CaT traces. A)
shows APD80, APD30 and APD3080, and B) shows CaTD30, CaTD80,
CaTD3080 and CaTMax. AP-CaT delay is the difference between the AP
and CaT upstroke times.
doi:10.1371/journal.pone.0056359.g001
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failing population range between 223 ms and 486 ms for
BCL = 1500 ms and between 167 ms and 277 ms for
BCL = 300 ms. An overlap in APD80 values between the non-
failing and failing populations exists for all BCLs.
As shown in Table S2 in Supplement S1, experimental
recordings obtained in failing and non-failing cardiac preparations
show a wide range of APD80 values, possibly explained by inter-
subject and intra-subject variability as well as differences in
experimental conditions and preparations between studies. Over-
all, experimentally-reported APD values are longer in failing
hearts than in non-failing hearts, as our simulation results show in
Fig. 3 A–C. In particular, our results for APD80 are comparable to
those of [26,27]. Both populations have significantly smaller
absolute values than those published by Bueckelmann et al [28,29],
however these values are significantly longer than those reported
in the other experimental studies we reviewed. Optical mapping
measurements in the left-ventricular transmural wedge report AP
prolongation at the epicardium and shortening at the endocardi-
um in failing versus non-failing hearts, indicating potential location
specific remodeling effects caused by heart failure [5].
AP triangulation. As shown in Fig. 3 D–F, AP triangulation
increases (i.e. APD3080 decreases) by a median value of between 7
and 10% at all BCLs in the failing population as compared to the
non-failing population, due to a decrease in APD30 relative to
APD80. The range in APD3080 values observed in the failing
population is larger than that observed in the non-failing
population. AP triangulation was not generally quantified in the
reviewed literature. However, visual inspection of APs given in
Figure 2. Sample AP and CaT traces obtained from the non-failing (blue) and failing (red) populations. Traces are shown for BCL = 1500
(A,C) and 300 ms (B,D). The AP for the standard ORd endocardial model is shown in black.
doi:10.1371/journal.pone.0056359.g002
Table 2. Experimental data summary.
Biomarker Increase in HF Decrease in HF No change in HF
Simulation Dmedian (1500 ms
BCL)
AP duration [28], [29], [33], [27], [4](a), [6](a) [5] : 19.7%
AP triangulation [28](b), [30](b) : 6.6%
CaT duration [34], [28], [32], [33] [5] : 51.7%
CaT triangulation [5] ; 11.6%
CaT max [28], [32], [33] [31] ; 44.4%
AP-CaT delay [34], [5] : 59.6%
a) [4] and [6] report a transmural flattening of APD in heart failure caused by prolongation of AP at the epicardium, but not in the midmyocardium or endocardium.
b) Not computed, see figures in those papers.
doi:10.1371/journal.pone.0056359.t002
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experimental studies [28,30] does reveal a marked increase in AP
triangulation in failing myocytes, in agreement with our simulation
results.
Calcium transient duration. CaTD80 is increased at all
BCLs compared with the non-failing population (Fig. 3 G–I). At
1500 ms cycle length, the median value of CaTD80 in the failing
population is 777 ms, a 51.7% increase in the median value
recorded for the non-failing population of 512 ms. The percentage
increase in the median value of the failing population decreases
with cycle length to a 36% increase compared to the non-failing
median value of 176 ms at a 300 ms cycle length. In agreement
with our findings, prolongation of CaT was consistently reported
in the reviewed literature, as summarized in Table 2. Numerical
values from experimental studies are shown in full in Table S3 in
Supplement S1.
Calcium transient triangulation. As shown in Fig. 3 J–L,
CaTD3080 values tend to increase in the failing population
relative to the non-failing population, corresponding to a decrease
in the CaT triangulation. This is in agreement with the only
experimental study to explicitly report CaT triangulation values by
[5] (see Table S6 in Supplement S1).
Our simulations show that CaTD3080 values display a complex
behaviour that is dependent upon the BCL in both the non-failing
and failing populations. At 1500 ms BCL, CaTD3080 values for
the non-failing population display a bimodality in their distribution
corresponding to two subpopulations of cells, the larger one close
to the value shown by the original ORd model, and the other one
with markedly reduced CaTD3080 values. The latter disappears
with decreasing BCLs below 1000 ms in the non-failing popula-
tion. In the failing population however, the bimodality appears for
BCLs ƒ 600 ms, with one sub-population appearing close to the
original ORd model value and one significantly greater, corre-
sponding to significantly decreased triangulation. At a BCL of
300 ms, the subpopulation with lower CaTD3080 values is a
larger proportion of the failing population.
Maximum cytosolic calcium concentration. Fig. 3 M–O
show that at all BCLs, both magnitude and range of CaTmax
values decrease in the failing population as compared to the non-
failing population. As BCL decreases, the range in values increases
in each population. At 1500 ms the non-failing population has a
median value of 2.82|10{4 mM, increasing to 9.0|10{4 mM at
300 ms cycle length. The failing population has a median value of
1.58|10{4 mM at 1500 ms, increasing to 2.96|10{4 mM at
300 ms cycle length. In both populations, the dispersion increases
as BCL decreases. The experimental values for maximum
cytosolic calcium vary widely in the literature, but a reduction in
failing hearts is reported consistently in line with our simulations
(see Table S5 in Supplement S1). One potential disagreement with
the experimental data is that Table S5 in Supplement S1 suggests
that systolic Ca may decrease with BCL contradicting what we see
in our simulations. As this trend for decreasing systolic Ca with
decreasing BCL spans multiple papers [31–33] there is a strong
possibility that differences in preparation of myocytes and
recording technique are responsible for this apparent effect.
AP-calcium transient delay. As illustrated in Fig. 3 P–Q, at
all BCLs, DAPCaT values tend to be larger and more variable in
the failing population than in the non-failing population, in
agreement with the only experimental study to measure the AP-
CaT delay [5]. Increased rise time to peak, as observed in
Gwathmey et al [34] and Lou et al [5] is also consistent with slowed
rise of the CaT, as shown in our simulations (Table S7 in
Supplement S1).
At 1500 ms the median value for DAPCaT in the failing
population is 17.4 ms, as opposed to 10.9 ms in the non-failing
population. At a cycle length of 300 ms, the median value for the
failing population is 13.1 ms and the median value for the non-
failing population is 8.6 ms.
Correlation between Biomarkers
In order to determine the potential correlation between the
different biomarkers values shown above, Fig. 4 plots values for
each biomarker against each of the other biomarker values for
each model in the non-failing and failing populations. As shown in
Fig. 4 (first column, first row), APD80 and APD3080 are
correlated as expected from the formulation of APD3080 and
increasing APD80 is associated with increased triangulation
(decreased APD3080) in both populations. The correlation is
found for all BCL, except for BCL = 300 ms, where the failing
population shows no such correlation (not shown). In general, AP
biomarkers are only weakly correlated with CaT biomarkers
suggesting the underlying ionic mechanisms driving changes in
these biomarkers are different. The exception is APD80 at
1500 ms BCL in the failing population, which shows a correlation
with CaTD3080.
Fig. 4 indicates that calcium biomarkers (CaTD80, CaTD3080,
CaTMax and DAPCaT) show strong correlation with one
another. In general, increased CaTD80 is correlated with
decreased CaT triangulation (increased CaTD3080), decreased
CaTmax and increased DAPCaT. Increased triangulation (de-
creased CaTD3080) is also correlated with decreased CaTmax,
and increased DAPCaT in the non-failing population only. Finally
increased CaTmax is correlated with decreased DAPCaT. The
correlation shown between certain biomarkers may be explained
by common ionic mechanisms, as explored below using regression
analysis.
Regression Analysis
We further exploit the potential of a population-based
computational approach to investigate the relative importance of
ionic properties in determining changes in each biomarker in
failing versus non-failing human cardiomyoctes. The correlation
found in the previous section with respect to AP and Ca
biomarkers suggests that different ionic properties determine AP
and Ca biomarkers values, respectively, within each population.
We use regression analysis to establish which ionic currents
determine biomarker values in the failing versus non-failing
population. Fig. 5 shows regression coefficients for each of the
biomarkers under investigation at all BCLs in the non-failing (left)
and failing (right) populations. For clarity, only coefficients
reaching an absolute value greater than 0.2 are given (those that
come outside of the grey band in the plots). Regression coefficients
are shown for both failing and non-failing populations. Examples
of regression fits are shown in Fig. S1 A-D in Supplement S1.
Regression coefficients for all biomarkers at all BCLs are shown in
Tables S8–S19 in Supplement S1. The regression method
produces good fits as measured by the R2 values which lay in a
Figure 3. Histograms showing biomarker values obtained for the non-failing (blue) and failing (red) cell model populations.
Histograms shown are recorded at BCL = 1500 ms, 600 ms and 300 ms (A–C: APD80, D–F: APD3080, G–I: CaTD80, J–L: CaTD3080, M–O: CaTmax and
P-R: AP-CaT delay. In each panel, the circle indicates biomarker values obtained with the standard ORd model whereas the cross indicates the value
obtained with the ORd model including 60% downregulation of Gto , GCaL, Jup and GKr and 60% upregulation of GNaCa.
doi:10.1371/journal.pone.0056359.g003
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range between 0.75 and 0.98, with the exception of CaTD80 in
the failing case. R2 values for all regression fits are shown in Tables
S20 and S21 in Supplement S1.
In both the failing and non-failing populations, long APD80
values are correlated with low GKr, as shown by the large negative
correlation coefficient of around 20.9 (Fig. 5A,B). Regression
analysis also gives a small positive correlation of APD80 with GCaL
in the failing population that increases as BCL is decreased. In the
non-failing population the effect of GCaL shows no significant
change with BCL.
As expected from the strong correlation between APD80 and
AP triangulation shown in Fig. 4, large AP triangulation (i.e. small
APD3080 value) is correlated with low GKr, but unlike APD80
also with lowered GCaL, represented by the positive correlation
coefficients shown in Fig. 5C,D. Lowered GK1 also makes a small
contribution to the increase in triangulation. In both populations,
the ionic mechanisms determining APD3080 are heavily rate
dependent, with GKr being the most important factor at long
BCLs. At short BCLs of 350 ms and 300 ms AP morphology is
driven primarily by GCaL, especially in the failing population.
As illustrated in Fig. 5 E–L, CaTD80, CaTD3080, CaTmax
and DAPCaT are determined by Jup, GCaL and GNaCa in both
populations. This is consistent with their sharing the same
underlying mechanisms determining these properties, as suggested
by the strong correlations shown in Fig. 4. GKr also affected
CaTD3080 at longer cycle lengths in the failing population.
Negative correlation coefficients of Jup and GCaL for CaTD80,
CaTD3080 and DAPCaT indicate that low Jup and GCaL result in
prolonged and less triangular CaTs with increased delay between
the upstrokes of voltage and calcium. Positive correlation
coefficients of Jup and GCaL for CaTmax suggest that low Ca
systolic levels in the failing population are determined by small Jup
and GCaL. For each of the calcium transient biomarkers, the
action of Jup and GCaL was opposed by that of GNaCa. Despite
being upregulated in heart failure, GNaCa had a relatively smaller
importance on biomarker values in the failing population than in
the non-failing population. The relative importance of Jup and
GCaL is rate dependent, with GCaL becoming increasingly
important at shorter BCLs, as for AP triangulation. Note that
the failing population shows a very different cause for low
triangulation at long BCLs, with a negative correlation coefficient
suggesting that decreased GKr increases CaTD3080 and hence
decreases triangulation, the opposite result to that for APD3080.
Figure 4. Correlation plots of one biomarker against another at 600 ms BCL. Red denotes the failing population, blue denotes the non-
failing population, and the darker shade represents cells lying in the intersection between the two populations. Points which develop alternans are
removed from these plots. Each biomarker is plotted against each other.
doi:10.1371/journal.pone.0056359.g004
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Even when R2 coefficents are low, regression analysis can be
useful for identifying markedly non-linear responses in regions of
parameter space. The concomitant effects of the parameters Jup
and GCaL explain both the bimodality shown in Fig. 3 J–L and the
low R2 values for CaTD3080 regression fits. The non-linear
relationship between Jup and GCaL (as shown in Fig. S2 and
Figure 5. Regression coefficients obtained in the non-failing and failing populations. Coefficients are plotted at all cycle lengths for A,B)
APD80, C,D) APD3080, E,F) CaTD80, G,H) CaTD3080, I,J) CaT max and K,L) AP-CaT delay. For clarity, only regression coefficients with an absolute value
greater than 0.2 are plotted, denoted by the grey band.
doi:10.1371/journal.pone.0056359.g005
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discussed in Supplement S1) results in the majority of the
parameter space giving either a high or low value for this
biomarker. A relatively small region of parameter space separates
the two regions, indicating that a large change in either of these
parameters individually could produce similar effects in morphol-
ogy to a smaller change in both parameters simultaneously.
Alternans
Fig. 6 depicts the number of models displaying alternans in both
populations together with a heat map of the parameters used to
generate them. In the non-failing population beat-to-beat alter-
nans are observed in the amplitude of the calcium transient and in
the APD as BCL is decreased. Alternans onset begins in 36 non-
failing cells at BCL 350 ms and is apparent in 2241 of the non-
failing cells by BCL 300 ms. In the standard ORd model,
alternans are not observed until BCL ƒ 300 ms. 2:1 block is
reported at BCLƒ 250 ms for the standard ORd model by [15].
As can be seen in Fig. 6 A,C alternans occur in non-failing cell
models with a combination of low Jup and high GCaL.
In the failing population alternans occur in 64 cells at 350 ms
and in 2235 cells at a BCL of 300 ms, due to prolonged APD
associated with low GKr (Fig. 6 B,D), as demonstrated by the
regression analysis. Representative voltage and calcium traces for
both populations are shown in Fig. S3 in Supplement S1.
Discussion
In this study we have developed a population-based approach to
investigate the potential of mRNA expression levels measured in
failing human hearts to predict electrophysiological remodeling in
Figure 6. Occurrence of voltage and calcium alternans in the non-failing and failing populations. Colour scale indicates the proportion
of models displaying alternans in APD80 and/or CaTD80 for each value of each ionic conductance considered. A) There are 36 non-failing alternans
cases at 350 ms BCL. B) There are 64 failing alternans cases at 350 ms BCL. C) There are 2241 non-failing cells in alternans at 300 ms BCL. D) There are
2235 failing cell models in alternans at BCL 300 ms.
doi:10.1371/journal.pone.0056359.g006
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AP and CaT, as measured experimentally. Our population-based
approach takes into consideration natural variability that may
arise from a variety of sources, as well as uncertainty associated
with the extent to which mRNA expression affects functional
channel conductance at the cell membrane, and uncertainty in
electrophysiological measurements. This is in contrast to the
traditional approach of considering unique values of ionic
conductances in cardiac models of non-diseased and failing
human cardiomyocytes [15,30,35]. Our main findings are:
1. mRNA data associated with GCaL, GK1, GKs, GKr, SERCA,
Gto and GNaCa (as reported in [3]) predict prolongation and
increased triangulation of AP, prolongation and decreased
triangulation of Ca transients, decreased maximum systolic Ca,
and increased delay between Ca and Vm upstroke in failing
versus non-failing human cardiomyocytes, as reported in
experimental studies (Tables 2 and S1–S7 in Supplement S1);
2. AP biomarkers (namely APD80 and APD3080) are correlated
in both non-failing and failing cardiomyocytes, and are
primarily determined by GKr, and secondarily by GCaL and
GK1;
3. Ca biomarkers (including CaTD80, CaTD3080 and DAPCaT)
are correlated (but only weakly correlated with AP biomarkers)
and are primarily determined by Jup, GCaL and GNaCa;
4. ionic mechanisms underlying the occurrence of alternans are
different in the failing population versus the non-failing
population: alternans are primarily favoured by low GKr
values in failing human cardiomyocytes and by low SERCA
(Jup) and high GCaL in non-failing human cardiomyocytes.
The non-failing and failing populations of human ventricular
cell models are constructed based on the latest human ventricular
AP model [15], which was developed using a consistent and
extensive dataset of electrophysiological measurements obtained
from the left ventricular endocardium of non-diseased human
hearts. The non-failing cell model population includes human
ventricular cell models sharing the same equations but with ionic
conductances varying in+30% range with respect to control. The
overlap in the parameter ranges between the two populations
explains some (but not all) of the overlap in the histograms in
Fig. 3. Variability in ionic conductances lead to variability in
biomarker values, with each distribution centered around the
original ORd model value. Specifically, APD80 ranges from
201 ms and 362 ms for BCL = 1500 ms and from 158 ms and
248 ms for BCL = 300 ms, which is in range with the level of
variability reported in experimental measurements for non-
diseased human cardiomyocytes [15,16]. As shown in Table S2
in Supplement S1, APD values are very different from one study to
another, indicating important sources of variability related to
preparations and techniques specific to each study. This may
represent an important limitation for the construction of cardiac
models built using a variety of data from different laboratories
[36].
The failing cell model population is built by including 0–60%
downregulation of Gto, GCaL, GKr and SERCA and 0–60%
upregulation of INaCa, based on the data by [3]. Our simulations
predict changes in AP and Ca transients, which are in qualitative
agreement with experimental recordings summarized in Tables
S2–S7 in Supplement S1. Significant quantitative differences exist
between experimental studies and also with our simulation results,
which might be due to a range of causes including the type of heart
failure (non-ischæmic versus ischæmic), inter-subject variability,
preparation (isolated cells or tissue), recording technique, etc [37].
Changes in AP biomarkers are not strongly correlated with
changes in CaT biomarkers, suggesting that different ionic
mechanisms cause these biomarker changes. This is explicitly
demonstrated through linear regression. In particular different
causes determine the duration of AP and CaT in failing cardiac
myocytes, namely GKr for the AP, and SERCA and GCaL for the
Ca transient. In the reviewed comparative experimental studies,
AP and CaT prolongation occurred concurrently in heart failure.
Thus, our findings lead to the prediction that remodeling of both
calcium and potassium currents currents may have occurred in
these samples - remodeling of one component alone does not lead
to the changes seen in these experiments. It is worth noting that
[5] observed no significant prolongation of APD80 or CaTD80 at
the endocardium in the failing population, but did observe other
changes in CaT morphology. We suggest that correlation plots
may provide a method to investigate causes of biomarker changes
by plotting against biomarkers whose underlying regulatory
mechanisms are well known.
Our simulations also show significant rate-dependence in the
ionic conductances underlying changes in AP triangulation,
CaTD80, CaT triangulation and AP-CaT delay in failing and
non-failing cardiomyocytes. In particular, the significance of ICaL
in affecting the biomarkers under investigation increases at shorter
cycle lengths.
Our population based approach reveals conditions in which
alternans may appear at longer BCLs than in the original ORd
model. The form of alternans observed in the non-failing
population cannot occur in the failing population, as the
combination of parameters driving alternans in the non-failing
population is outside the parameter range for the failing
population. Similarly, the 2:1 block observed in the failing
population does not occur in the non-failing population as GKr
cannot attain sufficiently low values. Thus, the alternans effect is
different in each population, arising from different ionic mecha-
nisms. This suggests that alternans observed in failing and non-
failing hearts may have different causes, and could require
different interventions to correct.
In this study we have only examined one component of the
mRNA expression dataset presented by Ambrosi et al [3], namely
the changes that occur between non-failing and failing human left
ventricle. There are several other avenues of investigation still
open from this dataset, namely atrial differences and gender
specific differences. Whilst Ambrosi et al [3] noted no significant
difference between male and female left ventricles, other studies
have done so [1,14]. This novel population-based approach to
modelling disease states is a first step towards clinically relevant
modelling of disease states as the methodology is flexible enough to
be applied to any dataset in order to utilise the information
extracted from mRNA data.
Limitations
The non-failing human hearts studied are not necessarily
healthy, and so care must be taken in extrapolation from these
results to healthy humans [5]. Similarly, the term ‘heart failure’
describes a range of pathologies as shown in Table S1 in
Supplement S1, and so our results may not extend to all conditions
coming under the description ‘heart failure’. For example,
Ambrosi et al [3] reported a downregulation of NCX1 in non-
ischæmic but not ischæmic cardiomyopathy as compared to non-
failing hearts (see Table 1).
We do not include co-regulation of membrane ion channels in
our study, as this information is not available from Ambrosi et al
[3]. Co-regulation could have an effect upon the choice of
distribution used for the parameters in future studies.
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The presence of spatial heterogeneities in AP properties in the
left ventricle is consistently reported in humans [4,38]. We do not
directly address these heterogeneities in our study, although our
population approach does offer robustness against variability
resulting from this. Furthermore, many experimental studies use
isolated ventricular myocytes whose original location within the
heart is unclear. The left ventricular wedge studies [4–6] go some
way to addressing this issue, however intercellular coupling may
also affect action potentials as compared to isolated cells.
Our study inherits many of the difficulties in extrapolating from
mRNA expression data to functional membrane ion channels as
discussed in the introduction and reviewed in [11]. Furthermore,
we explicitly address only changes in conductance, and do not
consider other potential consequences of heart failure, such as
altered gating dynamics [39].
Supporting Information
Supplement S1 Supplementary figures and tables re-
ferred to in the text.
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